ACOT1

gene
On this page

Also known as ACH2CTE-1LACH2

Summary

ACOT1 (acyl-CoA thioesterase 1, HGNC:33128) is a protein-coding gene on chromosome 14q24.3, encoding Acyl-coenzyme A thioesterase 1 (Q86TX2). Catalyzes the hydrolysis of acyl-CoAs into free fatty acids and coenzyme A (CoASH), regulating their respective intracellular levels.

Enables fatty acyl-CoA hydrolase activity. Involved in acyl-CoA metabolic process; long-chain fatty acid metabolic process; and very long-chain fatty acid metabolic process. Located in cytosol.

Source: NCBI Gene 641371 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 234 total — 1 pathogenic
  • Druggable target: yes
  • MANE Select transcript: NM_001037161

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33128
Approved symbolACOT1
Nameacyl-CoA thioesterase 1
Location14q24.3
Locus typegene with protein product
StatusApproved
AliasesACH2, CTE-1, LACH2
Ensembl geneENSG00000184227
Ensembl biotypeprotein_coding
OMIM614313
Entrez641371

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000311148, ENST00000557556

RefSeq mRNA: 1 — MANE Select: NM_001037161 NM_001037161

CCDS: CCDS32117

Canonical transcript exons

ENST00000311148 — 3 exons

ExonStartEnd
ENSE000009119307354305073543796
ENSE000011975587353714373537878
ENSE000017637517354149373541695

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 88.05.

FANTOM5 (CAGE): breadth broad, TPM avg 0.8434 / max 111.2100, expressed in 358 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
1405390.4449195
1405410.134462
1405380.122932
1405400.073131
1405420.068029

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.05gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.82gold quality
right lobe of liverUBERON:000111487.48gold quality
smooth muscle tissueUBERON:000113585.63gold quality
heart left ventricleUBERON:000208484.96gold quality
gastrocnemiusUBERON:000138884.42gold quality
liverUBERON:000210784.40gold quality
muscle of legUBERON:000138384.11gold quality
apex of heartUBERON:000209883.83gold quality
mucosa of stomachUBERON:000119983.05gold quality
heartUBERON:000094882.98gold quality
adult mammalian kidneyUBERON:000008282.69gold quality
right adrenal glandUBERON:000123382.05gold quality
lower esophagus muscularis layerUBERON:003583381.95gold quality
lower esophagusUBERON:001347381.94gold quality
left coronary arteryUBERON:000162681.77gold quality
hindlimb stylopod muscleUBERON:000425281.67gold quality
subcutaneous adipose tissueUBERON:000219081.60gold quality
right atrium auricular regionUBERON:000663181.33gold quality
popliteal arteryUBERON:000225081.28gold quality
left adrenal gland cortexUBERON:003582581.27gold quality
esophagogastric junction muscularis propriaUBERON:003584181.25gold quality
tibial arteryUBERON:000761081.23gold quality
left adrenal glandUBERON:000123481.19gold quality
right adrenal gland cortexUBERON:003582780.86gold quality
muscle layer of sigmoid colonUBERON:003580580.76gold quality
adipose tissueUBERON:000101380.44gold quality
omental fat padUBERON:001041478.93gold quality
adrenal glandUBERON:000236978.85gold quality
duodenumUBERON:000211478.53gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes17.45
E-MTAB-6142no166.67

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

19 targeting ACOT1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-8485100.0077.574731
HSA-MIR-569699.9872.364487
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-365899.9673.874379
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-427199.8868.322244
HSA-MIR-579-3P99.8671.663628
HSA-MIR-394199.8670.542735
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-3180-5P99.8269.122422
HSA-MIR-46699.6770.852863
HSA-MIR-664A-3P99.2271.082696
HSA-MIR-3688-5P99.1269.671091
HSA-MIR-60398.5868.281603
HSA-MIR-4717-5P98.1967.97894
HSA-MIR-66597.6065.641781
HSA-MIR-4670-3P97.3768.351378
HSA-MIR-6734-5P95.7065.56950

Literature-anchored findings (GeneRIF, showing 4)

  • that increased expression of ACOT1 is correlated with pivotal clinicopathological parameters and poor prognosis in gastric adenocarcinoma through increased expression of the potential tumor-promoting protein GLI3 (PMID:29555575)
  • The Thioesterase ACOT1 as a Regulator of Lipid Metabolism in Type 2 Diabetes Detected in a Multi-Omics Study of Human Liver. (PMID:34520261)
  • Acyl-Coa Thioesterases: A Rheostat That Controls Activated Fatty Acids Modulates Dengue Virus Serotype 2 Replication. (PMID:35215835)
  • Genes ACOT1, GSTM1, SIGLEC14 and UGT2B17 are identified as highly absent genes in gastric cancer population. (PMID:36109518)

Cross-species orthologs

16 orthologs

OrganismSymbolGene ID
danio_rerioacot20ENSDARG00000042510
danio_rerioacot21ENSDARG00000042513
danio_rerioacot22ENSDARG00000058945
mus_musculusAcot2ENSMUSG00000021226
mus_musculusAcot3ENSMUSG00000021228
mus_musculusAcot5ENSMUSG00000042540
mus_musculusAcot1ENSMUSG00000072949
rattus_norvegicusAcot2ENSRNOG00000010134
rattus_norvegicusAcot3ENSRNOG00000027960
rattus_norvegicusAcot5ENSRNOG00000032508
rattus_norvegicusAcot5ENSRNOG00000053460
rattus_norvegicusAcot1ENSRNOG00000055221
caenorhabditis_elegansC31H5.6WBGENE00007857
caenorhabditis_elegansWBGENE00019404
caenorhabditis_elegansT05E7.1WBGENE00020258
caenorhabditis_elegansW03D8.8WBGENE00020989

Paralogs (4): ACOT2 (ENSG00000119673), BAAT (ENSG00000136881), ACOT4 (ENSG00000177465), ACOT6 (ENSG00000205669)

Protein

Protein identifiers

Acyl-coenzyme A thioesterase 1Q86TX2 (reviewed: Q86TX2)

Alternative names: CTE-I, CTE-Ib, Inducible cytosolic acyl-coenzyme A thioester hydrolase, Long chain acyl-CoA thioester hydrolase, Palmitoyl-coenzyme A thioesterase

All UniProt accessions (3): E9KL42, G3V4F2, Q86TX2

UniProt curated annotations — full annotation on UniProt →

Function. Catalyzes the hydrolysis of acyl-CoAs into free fatty acids and coenzyme A (CoASH), regulating their respective intracellular levels. More active towards saturated and unsaturated long chain fatty acyl-CoAs (C12-C20).

Subunit / interactions. Monomer.

Subcellular location. Cytoplasm. Cytosol.

Pathway. Lipid metabolism; fatty acid metabolism.

Similarity. Belongs to the C/M/P thioester hydrolase family.

RefSeq proteins (1): NP_001032238* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR006862Thio_Ohase/aa_AcTrfaseDomain
IPR014940BAAT_CDomain
IPR016662Acyl-CoA_thioEstase_long-chainFamily
IPR029058AB_hydrolase_foldHomologous_superfamily
IPR042490Thio_Ohase/BAAT_NHomologous_superfamily

Pfam: PF04775, PF08840

Enzyme classification (BRENDA):

  • EC 3.1.2.2 — palmitoyl-CoA hydrolase (BRENDA: 40 organisms, 184 substrates, 159 inhibitors, 142 Km, 46 kcat entries)

Substrate kinetics (BRENDA)

34 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.

SubstrateKm (mM)Measurements
HEXADECANOYL-COA26
DODECANOYL-COA0.0018–0.32512
LAUROYL-COA0.0385–0.18510
OLEOYL-COA0.0014–0.00888
TETRADECANOYL-COA0.0016–0.0248
ARACHIDONOYL-COA0.0004–0.00926
DECANOYL-COA0.0027–0.0676
P-NITROPHENYL BUTYRATE0.61–1.886
PALMITOLEOYL-COA0.0014–0.0586
N-CARBOBENZOXY-L-TYROSINE P-NITROPHENYL ESTER0.043–0.1745
OCTADECANOYL-COA0.0004–0.0345
OCTANOYL-COA0.007–0.1185
EICOSANOYL-COA0.0004–0.00483
HEXANOYL-COA0.0055–0.0773
PALMITOYL-COA0.0033–0.0233

Catalyzed reactions (Rhea), 9 shown:

  • hexadecanoyl-CoA + H2O = hexadecanoate + CoA + H(+) (RHEA:16645)
  • dodecanoyl-CoA + H2O = dodecanoate + CoA + H(+) (RHEA:30135)
  • octadecanoyl-CoA + H2O = octadecanoate + CoA + H(+) (RHEA:30139)
  • decanoyl-CoA + H2O = decanoate + CoA + H(+) (RHEA:40059)
  • tetradecanoyl-CoA + H2O = tetradecanoate + CoA + H(+) (RHEA:40119)
  • (9Z)-hexadecenoyl-CoA + H2O = (9Z)-hexadecenoate + CoA + H(+) (RHEA:40131)
  • (9Z)-octadecenoyl-CoA + H2O = (9Z)-octadecenoate + CoA + H(+) (RHEA:40139)
  • eicosanoyl-CoA + H2O = eicosanoate + CoA + H(+) (RHEA:40147)
  • (9E)-octadecenoyl-CoA + H2O = (9E)-octadecenoate + CoA + H(+) (RHEA:40723)

UniProt features (6 total): active site 3, initiator methionine 1, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86TX2-F196.650.96

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 232 (charge relay system); 326 (charge relay system); 360 (charge relay system)

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-77289Mitochondrial Fatty Acid Beta-Oxidation
R-HSA-1430728Metabolism
R-HSA-556833Metabolism of lipids
R-HSA-8978868Fatty acid metabolism

MSigDB gene sets: 77 (showing top): GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS, LA_MEN1_TARGETS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, chr14q24, GOBP_AMIDE_METABOLIC_PROCESS, FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP, GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS

GO Biological Process (6): very long-chain fatty acid metabolic process (GO:0000038), long-chain fatty acid metabolic process (GO:0001676), fatty acid metabolic process (GO:0006631), acyl-CoA metabolic process (GO:0006637), lipid metabolic process (GO:0006629), monocarboxylic acid metabolic process (GO:0032787)

GO Molecular Function (5): fatty acyl-CoA hydrolase activity (GO:0047617), carboxylic ester hydrolase activity (GO:0052689), protein binding (GO:0005515), hydrolase activity (GO:0016787), thiolester hydrolase activity (GO:0016790)

GO Cellular Component (3): mitochondrion (GO:0005739), cytosol (GO:0005829), cytoplasm (GO:0005737)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
Fatty acid metabolism1
Metabolism1
Metabolism of lipids1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
fatty acid metabolic process2
hydrolase activity, acting on ester bonds2
cytoplasm2
cellular anatomical structure2
lipid metabolic process1
monocarboxylic acid metabolic process1
nucleoside phosphate metabolic process1
sulfur compound metabolic process1
purine-containing compound metabolic process1
primary metabolic process1
carboxylic acid metabolic process1
acyl-CoA hydrolase activity1
binding1
catalytic activity1
intracellular membrane-bounded organelle1
intracellular anatomical structure1

Protein interactions and networks

STRING

938 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ACOT1ACOT8O14734951
ACOT1PPARAQ07869796
ACOT1ACOT7O00154775
ACOT1EHHADHQ08426596
ACOT1HEATR4Q86WZ0588
ACOT1ACOT13Q9NPJ3567
ACOT1ACOX1Q15067538
ACOT1RBM8AQ9Y5S9521
ACOT1ACOT11Q8WXI4476
ACOT1FABP5Q01469475
ACOT1ACOT9Q9Y305465
ACOT1PDK4Q16654455
ACOT1CD4P01730448
ACOT1CPT2P23786446
ACOT1HMGCS2P54868440

IntAct

36 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
SLC35A5TNKSpsi-mi:“MI:0914”(association)0.640
TFAP2AACOT1psi-mi:“MI:0915”(physical association)0.560
PCNAPOM121Cpsi-mi:“MI:0914”(association)0.550
ACOT2ACOT1psi-mi:“MI:0914”(association)0.530
KCNA10GAPDHSpsi-mi:“MI:0914”(association)0.530
AIFM1HAX1psi-mi:“MI:2364”(proximity)0.420
HHATLACOT1psi-mi:“MI:0915”(physical association)0.400
PATZ1ACOT1psi-mi:“MI:0915”(physical association)0.400
Chmp4bBDP1psi-mi:“MI:0914”(association)0.350
HSCBRBP5psi-mi:“MI:0914”(association)0.350
ZFP69BCNPpsi-mi:“MI:0914”(association)0.350
TMPRSS11ERAB4Apsi-mi:“MI:0914”(association)0.350
TFAP2ATFAP2Dpsi-mi:“MI:0914”(association)0.350
CNPUBBpsi-mi:“MI:0914”(association)0.350
SPG7TUBA4Apsi-mi:“MI:0914”(association)0.350
FECHGTPBP10psi-mi:“MI:0914”(association)0.350
AIFM1NUDT19psi-mi:“MI:2364”(proximity)0.270
AURKAIP1VWA8psi-mi:“MI:2364”(proximity)0.270
VWA8psi-mi:“MI:2364”(proximity)0.270
HSPD1VWA8psi-mi:“MI:2364”(proximity)0.270
COX14NUDT19psi-mi:“MI:2364”(proximity)0.270
COX4I1HAX1psi-mi:“MI:2364”(proximity)0.270
MGST3VWA8psi-mi:“MI:2364”(proximity)0.270
PDK1VWA8psi-mi:“MI:2364”(proximity)0.270
SCO1HAX1psi-mi:“MI:2364”(proximity)0.270
SFXN1HAX1psi-mi:“MI:2364”(proximity)0.270
TRMT61BVWA8psi-mi:“MI:2364”(proximity)0.270
IMMP2LMRPL45psi-mi:“MI:2364”(proximity)0.270

BioGRID (142): ACOT1 (Affinity Capture-MS), ACOT1 (Affinity Capture-MS), ACOT1 (Affinity Capture-MS), ACOT1 (Affinity Capture-MS), ACOT1 (Affinity Capture-MS), ACOT1 (Affinity Capture-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS), ACOT1 (Proximity Label-MS)

ESM2 similar proteins: A0A1D5PJB7, A1A4Q9, A5YM72, A6NLP5, D3KCC4, I3L5V6, O43292, P10938, Q00973, Q05B52, Q09200, Q10468, Q14623, Q148G5, Q16586, Q2V8X7, Q3SZV0, Q561R2, Q5E9M9, Q5M868, Q5ZL13, Q66H45, Q69ZF3, Q6P3D0, Q6P7A1, Q6P9Z4, Q6SZW1, Q6TEC1, Q6ZPS2, Q7TMC8, Q864R5, Q86TX2, Q8IXI1, Q8N0W3, Q8N3Y3, Q8N6R0, Q8NF37, Q8NI29, Q8TCD5, Q8VBW8

Diamond homologs: A2AKK5, O55137, O55171, O88267, P49753, Q14032, Q32Q92, Q3I5F7, Q5FVR5, Q63276, Q6Q2Z6, Q86TX2, Q8BGG9, Q8BWN8, Q8N9L9, Q91X34, Q9QYR7, Q9QYR9

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 47 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Mitochondrial protein degradation621.4×1e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

234 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance184
Likely benign24
Benign4

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
375394NM_001037161.2(ACOT1):c.410_423del (p.Glu137fs)Pathogenic

SpliceAI

939 predictions. Top by Δscore:

VariantEffectΔscore
14:73539729:G:GTdonor_gain1.0000
14:73541230:T:Aacceptor_gain1.0000
14:73541479:T:TAacceptor_gain1.0000
14:73541489:CAAG:Cacceptor_loss1.0000
14:73541490:A:AGacceptor_gain1.0000
14:73541491:A:Gacceptor_gain1.0000
14:73541491:A:Tacceptor_loss1.0000
14:73541492:G:Aacceptor_loss1.0000
14:73541492:G:GCacceptor_gain1.0000
14:73541492:GA:Gacceptor_gain1.0000
14:73541492:GAA:Gacceptor_gain1.0000
14:73541492:GAAC:Gacceptor_gain1.0000
14:73541492:GAACC:Gacceptor_gain1.0000
14:73541691:CTGAG:Cdonor_gain1.0000
14:73541692:TGAG:Tdonor_gain1.0000
14:73541693:GAG:Gdonor_gain1.0000
14:73541693:GAGG:Gdonor_gain1.0000
14:73541694:AG:Adonor_gain1.0000
14:73541694:AGGT:Adonor_loss1.0000
14:73541695:GG:Gdonor_gain1.0000
14:73541696:G:GAdonor_loss1.0000
14:73541696:G:GGdonor_gain1.0000
14:73539718:G:GTdonor_gain0.9900
14:73539817:GGG:Gdonor_gain0.9900
14:73539818:GGG:Gdonor_gain0.9900
14:73541494:A:AGacceptor_gain0.9900
14:73541494:ACCT:Aacceptor_gain0.9900
14:73541494:ACCTG:Aacceptor_gain0.9900
14:73541495:C:Gacceptor_gain0.9900
14:73543045:CTCA:Cacceptor_loss0.9900

AlphaMissense

2700 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:73543366:A:CD326A0.983
14:73543380:A:CS331R0.983
14:73543382:T:AS331R0.983
14:73543382:T:GS331R0.983
14:73537557:T:CF46L0.982
14:73537559:C:AF46L0.982
14:73537559:C:GF46L0.982
14:73543365:G:CD326H0.982
14:73543469:C:AH360Q0.982
14:73543469:C:GH360Q0.982
14:73543584:T:AW399R0.982
14:73543584:T:CW399R0.982
14:73543366:A:TD326V0.981
14:73537635:T:CF72L0.980
14:73537637:C:AF72L0.980
14:73537637:C:GF72L0.980
14:73543467:C:GH360D0.980
14:73541561:A:CS176R0.979
14:73541563:T:AS176R0.979
14:73541563:T:GS176R0.979
14:73543367:C:AD326E0.977
14:73543367:C:GD326E0.977
14:73537575:T:GY52D0.976
14:73543154:C:AN255K0.974
14:73543154:C:GN255K0.974
14:73543586:G:CW399C0.973
14:73543586:G:TW399C0.973
14:73543374:T:AW329R0.972
14:73543374:T:CW329R0.972
14:73537706:G:CK95N0.970

dbSNP variants (sampled 300 via entrez): RS1000028636 (14:73517976 C>T), RS1000042399 (14:73496632 T>C), RS1000135040 (14:73524860 A>G), RS1000190326 (14:73543268 G>A), RS1000326850 (14:73497772 A>G), RS1000343396 (14:73502024 A>C,G), RS1000390861 (14:73510014 C>T), RS1000414511 (14:73491297 C>A,G), RS1000468253 (14:73491491 C>G,T), RS1000524285 (14:73530368 T>C), RS1000552373 (14:73529764 C>T), RS1000764213 (14:73490900 C>A,G,T), RS1000801752 (14:73493195 C>T), RS1000947156 (14:73497511 C>T), RS1001148371 (14:73516853 G>T)

Disease associations

OMIM: gene MIM:614313 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL2189136 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs758109ACOT1, HEATR4, RIOX10.000

CTD chemical–gene interactions

48 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases methylation, decreases expression2
Acetaminophendecreases expression2
bisphenol Fincreases expression1
lasiocarpinedecreases expression1
methyleugenoldecreases expression1
chlortolurondecreases expression1
deoxynivalenoldecreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
sodium arseniteincreases expression1
ochratoxin Adecreases expression1
benzo(e)pyrenedecreases methylation1
aflatoxin B2decreases methylation1
nivalenoldecreases expression1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic aciddecreases expression1
GW 4064decreases expression, affects cotreatment1
GW 7647increases expression1
6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oximeincreases expression1
nutlin 3affects cotreatment, increases secretion1
bisphenol Bincreases expression1
Grape Seed Proanthocyanidinsaffects cotreatment, increases expression1
bisphenol Sincreases expression1
bisphenol AFincreases expression1
Temozolomidedecreases expression1
Sunitinibincreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Benzo(a)pyrenedecreases expression1
Cadmiumincreases abundance, increases expression1
Caffeinedecreases phosphorylation1
Catechinaffects cotreatment, increases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL2209148BindingInhibition of ACOT1 binding to FP-biotin in [12C][14N]-lysine, arginine and [13C6][15N2]-lysine, arginine labeled HEK293T cells at 20 uM after 1 hr by isotopic activity-based protein profiling-MudPIT assayDiscovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1. — J Med Chem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.